A Landmark Study on Palliation of Bone Mets PainWhen a primary cancer such as cancer of the breast, prostate or lung spreads to the bone (bone mets), treatment strategies become complex. In today’s world of oncology, better systemic chemotherapies can add months and even years to a patient’s life; in addition, local cancer control of […] KEEP READING
What You Should Know About CartilageOne of the most fascinating components of the human body is cartilage, an incredibly versatile material. Trying to describe cartilage is like the six blind men who try to figure out what an elephant is: “The elephant is like a pillar,” said the man who touched his leg. “Oh no! […] KEEP READING
How Stress Makes Essential Tremor WorseEssential tremor (ET) is the most common form of uncontrollable rhythmic shaking, though it is sometimes misdiagnosed as Parkinson’s disease. The involuntary trembling results from abnormal communication between certain areas of the brain (cerebellum, thalamus, and brain stem). It is estimated that 10 million Americans suffer from ET, though many […] KEEP READING
The FDA has approved ArteraAI Prostate, an innovative AI tool trained on thousands of biopsy images and clinical data, to help assess the risk of prostate cancer progression and personalize treatment plans. Doctors and patients can now benefit from faster, more accurate risk predictions. CONTINUE
“Nothing makes me angrier than calling my cable service and having to wade through voice menus to finally talk to a REAL PERSON after 10 minutes of following the stupid steps!” We’ve all been there, right? It used to be so simple to get the help you need from an empathic customer service representative. Well, […] CONTINUE
The least expensive and most efficient test used to screen men for prostate cancer (PCa) is the PSA blood test. However, the test is not specific for prostate cancer, so a suspicious result (abnormally high or rising) requires further information. Until fairly recently, the conventional next step was a TRUS-guided needle biopsy. Unfortunately, this method […] CONTINUE
When facing a prostate cancer diagnosis, knowing how aggressive the disease is makes all the difference in treatment choices. A new large-scale study shows that Artificial Intelligence, working with MRI scans, may help predict tumor grade with surprising accuracy—promising more clarity for patients and their doctors. CONTINUE
Today’s multiparametric MRI (mpMRI) has revolutionized the prostate cancer (PCa) world. Thanks to its high resolution, 3-dimensional imaging done by a powerful 3 Tesla (3T) magnet, experienced radiologists are able to identify areas that are suspicious for clinically significant PCa (csPCa). This helps avoid unnecessary biopsies, but if a biopsy is indicated, the area can […] CONTINUE
When a patient is told, “You have prostate cancer,” it’s not a simple one-size-fits-all diagnosis. The doctor will then give the patient an idea of how severe his cancer is. If his prostate cancer (PCa) is still localized (that is, contained within the gland), the doctor will specify if it is low, intermediate, or high […] CONTINUE
The interpretation of medical images is “a task that lies at the heart of the radiologist’s work.”[i] In fact, the human element—a radiologist’s eyes and brain—is just as important as what a high resolution, 3- dimensional image depicts. Imaging types include x-ray, MRI, CT scan, ultrasound and PET scan, but no matter how advanced the […] CONTINUE
We’ve posted numerous blogs on the contributions of Artificial Intelligence (AI) to various aspects of MRI detection and diagnosis of prostate cancer (PCa). We’ve reported AI’s ability to predict metastasis, assign Gleason scores and PI-RADS scores, pinpoint tumor margins for focal therapy, rule out need for biopsy, predict PCa metastasis, and more—showing the accuracy and […] CONTINUE
If you’ve ever been involved in a simulation game, or a simulation training model, you are interacting with something that’s not really there but feels like it is. In fact, during the experience the same neurons in the brain are activated as if the simulation IS the real world. Thus, the brain can be functionally […] CONTINUE
Determining the risk level of localized prostate cancer (PCa) at the time of diagnosis is often closer to an art than a science. Is it low risk, favorable intermediate risk, unfavorable intermediate risk, or high risk? Precision matters, because it determines the treatment plan’s projected probability of success. If the treatment isn’t aggressive enough, there’s […] CONTINUE
